Tofacitinib 5 mg twice daily ( DrugBank: Tofacitinib )

1 disease

ID	Disease name (Link within this page)	Number of trials
84	Sarcoidosis	1

84. Sarcoidosis

Clinical trials : 149 / Drugs : 202 - (DrugBank : 78) / Drug target genes : 66 - Drug target pathways : 169

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03910543 (ClinicalTrials.gov)	April 11, 2019	4/4/2019	Open-label Trial of Tofacitinib in Cutaneous Sarcoidosis and Granuloma Annulare	Open-label Trial of Tofacitinib in Cutaneous Sarcoidosis and Granuloma Annulare	Cutaneous Sarcoidosis;Granuloma Annulare	Drug: Tofacitinib 5 mg twice daily	Yale University	Pfizer	Completed	18 Years	N/A	All	15	Phase 1	United States

First Previous1Next Last